Literature DB >> 2105544

Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies.

P M Ford1, D Brunet, D P Lillicrap, S E Ford.   

Abstract

Lupus anticoagulant and antiphospholipid antibodies are associated with thromboembolic phenomena in individuals both with and without systemic lupus erythematosus. A 32-year-old woman (the index case) with lupus anticoagulant, multiple cerebrovascular events, and a family history of premature stroke raised the possibility of a familial diathesis. Histories or interviews, examinations, and blood tests were obtained for 23 members of four generations of her family. Four individuals had suffered strokes and three more had suffered neurologic symptoms. Two living individuals who had suffered strokes, two individuals with neurologic symptoms, and five asymptomatic individuals had antiphospholipid activity in their blood. In addition, a cousin of the index case was found to have systemic lupus erythematosus and antiphospholipid activity. Elevated concentrations of von Willebrand factor antigen were found associated with some positive lupus anticoagulant assays, the highest concentrations in the two individuals with stroke. The characteristic presentation of the index case and her good response to treatment suggests that further studies of families in whom antiphospholipid antibodies may represent a risk factor for stroke is worthwhile.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105544     DOI: 10.1161/01.str.21.1.66

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  4 in total

Review 1.  Antiphospholipid syndrome: genetic review.

Authors:  Bahram Namjou
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

2.  Coincidence of familial platelet glycoprotein Ib/IX deficiency (Bernard-Soulier syndrome), idiopathic autoantibody against platelet glycoprotein Ib/IX, familial appearance of antiphospholipid antibodies, and familial factor XII deficiency.

Authors:  W Korte; C Baumgartner; A Feldges; C Knöpfl; S Lutz; A Lenz; W Riesen; L Schmid
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

3.  Antiphospholipid antibodies syndrome and cerebral ischemia.

Authors:  S Severi; M Ghezzi; M Felici; A Miele
Journal:  Ital J Neurol Sci       Date:  1993-03

4.  Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features.

Authors:  A M Chancellor; R E Cull; D C Kilpatrick; C P Warlow
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.